Cargando…
An Update in Guillain-Barré Syndrome
Guillain-Barré syndrome (GBS) was first described in 1916 (Guillain G, 1916) and is approaching its 100th anniversary. Our knowledge of the syndrome has hugely expanded since that time. Once originally considered to be only demyelinating in pathology we now recognise both axonal and demyelinating su...
Autor principal: | Winer, J. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910670/ https://www.ncbi.nlm.nih.gov/pubmed/24511391 http://dx.doi.org/10.1155/2014/793024 |
Ejemplares similares
-
Biological Drugs in Guillain-Barré Syndrome: An Update
por: Motamed-Gorji, Nazgol, et al.
Publicado: (2017) -
An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome
por: Sheikh, Kazim A, et al.
Publicado: (2010) -
Role of Campylobacter jejuni Infection in the Pathogenesis of Guillain-Barré Syndrome: An Update
por: Nyati, Kishan Kumar, et al.
Publicado: (2013) -
Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review
por: Sheikh, Abu Baker, et al.
Publicado: (2021) -
Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)